Correlation Between Macquarie and Actinogen Medical

Can any of the company-specific risk be diversified away by investing in both Macquarie and Actinogen Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Macquarie and Actinogen Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Macquarie Group and Actinogen Medical, you can compare the effects of market volatilities on Macquarie and Actinogen Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Macquarie with a short position of Actinogen Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Macquarie and Actinogen Medical.

Diversification Opportunities for Macquarie and Actinogen Medical

0.26

Correlation Coefficient

Macquarie  Actinogen Medical

Modest diversification

The 3 months correlation between Macquarie and Actinogen is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Macquarie Group and Actinogen Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinogen Medical and Macquarie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Macquarie Group are associated (or correlated) with Actinogen Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinogen Medical has no effect on the direction of Macquarie i.e., Macquarie and Actinogen Medical go up and down completely randomly.

Pair Corralation between Macquarie and Actinogen Medical

Assuming the 90 days trading horizon Macquarie is expected to generate 3.11 times less return on investment than Actinogen Medical. But when comparing it to its historical volatility, Macquarie Group is 7.48 times less risky than Actinogen Medical. It trades about 0.07 of its potential returns per unit of risk. Actinogen Medical is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  3.75  in Actinogen Medical on October 4, 2024 and sell it today you would lose (1.25) from holding Actinogen Medical or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Macquarie Group  vs.  Actinogen Medical

Macquarie Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Macquarie Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Macquarie is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Actinogen Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Actinogen Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Macquarie and Actinogen Medical

The main advantage of trading using opposite Macquarie and Actinogen Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Macquarie position performs unexpectedly, Actinogen Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinogen Medical will offset losses from the drop in Actinogen Medical's long position.

The idea behind Macquarie Group and Actinogen Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.